Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-31

Clinical Trial Update: Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating the safety of topical tranexamic acid in high-risk total joint arthroplasty patients was withdrawn. The safety considerations inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranexamic acid (topical) (tranexamic acid)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Pulmonary Embolism, Deep Vein Thrombosis | Phase 4 | Status: WITHDRAWN